Consolidation of Variable Interest Entity (Tables)

3 Months Ended

Mar. 31, 2016

Equity Method Investments And Joint Ventures [Abstract]

The financial information in the table below summarizes the combined results of operations of Milestone Scientific, and its subsidiaries including Milestone Medical and Milestone Education (each a variable interest entity) on a pro forma basis as though the companies had been combined as of the beginning of the earliest period presented. The pro forma financial information is presented for informational purposes only and is not indicative of the result of operations that would have been achieved if the consolidation had taken place at the beginning of the period presented.

	March 31, 2015 Pro Forma
Total revenue	$	2,791,103
Cost of products sold		933,148
Gross Profit		1,857,955
Selling, general and administrative expenses		2,683,757
Research and development expenses		143,685
Operating expenses		2,827,442
Loss from operations		(969,643	)
Other expenses		-
Interest expense		(369	)
Interest income		1,213
Loss before Provision for Income Tax		(968,643	)
Provision for Income Tax		-
Loss before equity in net earnings of equity investments		(968,643	)
Loss on earnings from Milestone Medical Inc.		(450,160	)
Loss on earnings from Education Joint Venture		(4,215	)
Gain on earnings from China Joint Venture		96,674
Loss in equity investments		(357,701	)
Net loss		(1,326,344	)
Less: Net loss attributable to the noncontrolling interests		(457,436	)
Net loss attributable to Milestone Scientific Inc.	$	(868,908	)